

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.95548112 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.95548112 |
| 3 | axon ensheathment (GO:0008366) | 6.46560262 |
| 4 | ensheathment of neurons (GO:0007272) | 6.46560262 |
| 5 | myelination (GO:0042552) | 6.46486819 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.80597302 |
| 7 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.37789444 |
| 8 | fatty acid elongation (GO:0030497) | 5.33956665 |
| 9 | negative regulation of neurotransmitter transport (GO:0051589) | 4.85743255 |
| 10 | L-amino acid import (GO:0043092) | 4.60576142 |
| 11 | presynaptic membrane organization (GO:0097090) | 4.47632590 |
| 12 | myelin maintenance (GO:0043217) | 4.46072873 |
| 13 | presynaptic membrane assembly (GO:0097105) | 4.36784930 |
| 14 | oligodendrocyte differentiation (GO:0048709) | 4.20239156 |
| 15 | establishment of mitochondrion localization (GO:0051654) | 4.14613947 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.00987633 |
| 17 | response to lipoprotein particle (GO:0055094) | 4.00068284 |
| 18 | glycerophospholipid catabolic process (GO:0046475) | 3.90976115 |
| 19 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.89365941 |
| 20 | import into cell (GO:0098657) | 3.81989266 |
| 21 | regulation of collateral sprouting (GO:0048670) | 3.80212740 |
| 22 | asymmetric protein localization (GO:0008105) | 3.70450888 |
| 23 | response to methylmercury (GO:0051597) | 3.63317413 |
| 24 | adult walking behavior (GO:0007628) | 3.62553559 |
| 25 | transmission of nerve impulse (GO:0019226) | 3.60292430 |
| 26 | astrocyte development (GO:0014002) | 3.59329141 |
| 27 | amino acid import (GO:0043090) | 3.56415275 |
| 28 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.44942326 |
| 29 | apical protein localization (GO:0045176) | 3.43143319 |
| 30 | adhesion of symbiont to host cell (GO:0044650) | 3.43026146 |
| 31 | virion attachment to host cell (GO:0019062) | 3.43026146 |
| 32 | negative regulation of protein localization to cell surface (GO:2000009) | 3.42732559 |
| 33 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.40733673 |
| 34 | protein palmitoylation (GO:0018345) | 3.40484560 |
| 35 | photoreceptor cell differentiation (GO:0046530) | 3.38665507 |
| 36 | eye photoreceptor cell differentiation (GO:0001754) | 3.38665507 |
| 37 | surfactant homeostasis (GO:0043129) | 3.35344776 |
| 38 | response to redox state (GO:0051775) | 3.32863255 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.31883886 |
| 40 | negative regulation of axonogenesis (GO:0050771) | 3.31239038 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.28519401 |
| 42 | cholesterol biosynthetic process (GO:0006695) | 3.27641180 |
| 43 | nerve growth factor signaling pathway (GO:0038180) | 3.25676837 |
| 44 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.25086480 |
| 45 | magnesium ion transport (GO:0015693) | 3.22327903 |
| 46 | positive regulation of action potential (GO:0045760) | 3.19243968 |
| 47 | activated T cell proliferation (GO:0050798) | 3.16056053 |
| 48 | peripheral nervous system axon ensheathment (GO:0032292) | 3.14307940 |
| 49 | myelination in peripheral nervous system (GO:0022011) | 3.14307940 |
| 50 | Golgi to endosome transport (GO:0006895) | 3.11916109 |
| 51 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.09419920 |
| 52 | neuronal ion channel clustering (GO:0045161) | 3.06474569 |
| 53 | cellular extravasation (GO:0045123) | 3.06297507 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 3.06202815 |
| 55 | neuron remodeling (GO:0016322) | 3.06074411 |
| 56 | locomotory exploration behavior (GO:0035641) | 3.05872979 |
| 57 | establishment of nucleus localization (GO:0040023) | 3.04448409 |
| 58 | phospholipid translocation (GO:0045332) | 3.03554985 |
| 59 | lipid translocation (GO:0034204) | 3.03554985 |
| 60 | neuron recognition (GO:0008038) | 2.98758687 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 2.96487443 |
| 62 | dendrite morphogenesis (GO:0048813) | 2.95191382 |
| 63 | amyloid precursor protein metabolic process (GO:0042982) | 2.94690265 |
| 64 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.94118117 |
| 65 | substantia nigra development (GO:0021762) | 2.94112651 |
| 66 | cellular response to ethanol (GO:0071361) | 2.93533342 |
| 67 | L-serine transport (GO:0015825) | 2.92681207 |
| 68 | creatine metabolic process (GO:0006600) | 2.90660610 |
| 69 | negative regulation of axon extension (GO:0030517) | 2.90180241 |
| 70 | regulation of beta-amyloid formation (GO:1902003) | 2.89924174 |
| 71 | sterol biosynthetic process (GO:0016126) | 2.86704146 |
| 72 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82061174 |
| 73 | chemical homeostasis within a tissue (GO:0048875) | 2.82024304 |
| 74 | glycosylceramide metabolic process (GO:0006677) | 2.81711446 |
| 75 | membrane tubulation (GO:0097320) | 2.81283553 |
| 76 | clathrin coat assembly (GO:0048268) | 2.76984214 |
| 77 | axonal fasciculation (GO:0007413) | 2.76028288 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 2.74875647 |
| 79 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.73779100 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.69242315 |
| 81 | organ growth (GO:0035265) | 2.68770635 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.68297916 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66696216 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.66365894 |
| 85 | cellular response to epinephrine stimulus (GO:0071872) | 2.66363381 |
| 86 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.65616900 |
| 87 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65026427 |
| 88 | positive regulation of regulated secretory pathway (GO:1903307) | 2.63190953 |
| 89 | negative regulation of macroautophagy (GO:0016242) | 2.62680802 |
| 90 | positive regulation of mast cell degranulation (GO:0043306) | 2.62335134 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62335134 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.61282073 |
| 93 | positive regulation of glial cell differentiation (GO:0045687) | 2.61198507 |
| 94 | histone H2B ubiquitination (GO:0033523) | 2.60798114 |
| 95 | negative regulation of JUN kinase activity (GO:0043508) | 2.60023001 |
| 96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59806477 |
| 97 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.59188682 |
| 98 | histone H3-K36 demethylation (GO:0070544) | 2.57189042 |
| 99 | serine transport (GO:0032329) | 2.56946365 |
| 100 | cellular response to monoamine stimulus (GO:0071868) | 2.55847207 |
| 101 | cellular response to catecholamine stimulus (GO:0071870) | 2.55847207 |
| 102 | membrane assembly (GO:0071709) | 2.55808948 |
| 103 | synaptic vesicle maturation (GO:0016188) | 2.54771934 |
| 104 | mitochondrion transport along microtubule (GO:0047497) | 2.51797569 |
| 105 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51797569 |
| 106 | glial cell development (GO:0021782) | 2.51492415 |
| 107 | mating behavior (GO:0007617) | 2.50117442 |
| 108 | protein localization to endosome (GO:0036010) | 2.48753354 |
| 109 | positive regulation of gliogenesis (GO:0014015) | 2.48117206 |
| 110 | isoprenoid biosynthetic process (GO:0008299) | 2.47260852 |
| 111 | GPI anchor metabolic process (GO:0006505) | 2.47057684 |
| 112 | regulation of regulated secretory pathway (GO:1903305) | 2.46262424 |
| 113 | Golgi to plasma membrane protein transport (GO:0043001) | 2.45712718 |
| 114 | neurotransmitter uptake (GO:0001504) | 2.45712565 |
| 115 | negative regulation of exocytosis (GO:0045920) | 2.44000234 |
| 116 | negative regulation of synaptic transmission (GO:0050805) | 2.43779144 |
| 117 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.40357772 |
| 118 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.40048414 |
| 119 | axon development (GO:0061564) | 2.39995332 |
| 120 | peripheral nervous system development (GO:0007422) | 2.39643023 |
| 121 | GPI anchor biosynthetic process (GO:0006506) | 2.38661252 |
| 122 | cortical actin cytoskeleton organization (GO:0030866) | 2.38454158 |
| 123 | regulation of synaptic vesicle transport (GO:1902803) | 2.38400700 |
| 124 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.37830336 |
| 125 | adult locomotory behavior (GO:0008344) | 2.37427934 |
| 126 | response to hepatocyte growth factor (GO:0035728) | 2.37208913 |
| 127 | regulation of protein glycosylation (GO:0060049) | 2.37184380 |
| 128 | regulation of leukocyte degranulation (GO:0043300) | 2.35503894 |
| 129 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.34462549 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.34129921 |
| 131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.33398443 |
| 132 | positive regulation of Rap GTPase activity (GO:0032854) | 2.33295107 |
| 133 | regulation of Rac protein signal transduction (GO:0035020) | 2.32288556 |
| 134 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.30029940 |
| 135 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.29400214 |
| 136 | macrophage activation involved in immune response (GO:0002281) | 2.28869557 |
| 137 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28733042 |
| 138 | early endosome to late endosome transport (GO:0045022) | 2.28341587 |
| 139 | glutamate secretion (GO:0014047) | 2.24794124 |
| 140 | peptidyl-threonine phosphorylation (GO:0018107) | 2.24492119 |
| 141 | regulation of cellular amide metabolic process (GO:0034248) | 2.24230808 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.22672734 |
| 143 | suckling behavior (GO:0001967) | 2.21881641 |
| 144 | regulation of Rap GTPase activity (GO:0032317) | 2.18020588 |
| 145 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.17438600 |
| 146 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.17417252 |
| 147 | response to nerve growth factor (GO:1990089) | 2.17417252 |
| 148 | melanin biosynthetic process (GO:0042438) | 2.16122167 |
| 149 | glycosphingolipid catabolic process (GO:0046479) | 2.12958190 |
| 150 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.12913160 |
| 151 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.12625719 |
| 152 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.12496893 |
| 153 | protein targeting to vacuole (GO:0006623) | 2.12110250 |
| 154 | protein targeting to lysosome (GO:0006622) | 2.12110250 |
| 155 | establishment of protein localization to vacuole (GO:0072666) | 2.12110250 |
| 156 | peptidyl-threonine modification (GO:0018210) | 2.10444082 |
| 157 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.09594623 |
| 158 | cortical cytoskeleton organization (GO:0030865) | 2.09066901 |
| 159 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.06313171 |
| 160 | macroautophagy (GO:0016236) | 2.05866357 |
| 161 | proline transport (GO:0015824) | 2.04842153 |
| 162 | regulation of mast cell degranulation (GO:0043304) | 2.04170039 |
| 163 | positive regulation of receptor recycling (GO:0001921) | 2.03657324 |
| 164 | response to laminar fluid shear stress (GO:0034616) | 2.03320174 |
| 165 | Rap protein signal transduction (GO:0032486) | 2.02247096 |
| 166 | positive regulation of exocytosis (GO:0045921) | 2.01247554 |
| 167 | regulation of macrophage cytokine production (GO:0010935) | 1.98312777 |
| 168 | melanin metabolic process (GO:0006582) | 1.97716863 |
| 169 | exploration behavior (GO:0035640) | 1.97291070 |
| 170 | pyrimidine nucleobase catabolic process (GO:0006208) | 1.96820520 |
| 171 | regulation of pigment cell differentiation (GO:0050932) | 1.96594297 |
| 172 | nucleus localization (GO:0051647) | 1.96530224 |
| 173 | developmental pigmentation (GO:0048066) | 1.96052143 |
| 174 | negative regulation of complement activation (GO:0045916) | 1.95939561 |
| 175 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 1.95482281 |
| 176 | positive regulation of macrophage cytokine production (GO:0060907) | 1.95183326 |
| 177 | regulation of dendritic spine development (GO:0060998) | 1.94896413 |
| 178 | oligosaccharide catabolic process (GO:0009313) | 1.94714007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.62664516 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.51312517 |
| 3 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.61755749 |
| 4 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.49035917 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34926216 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32529777 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.24536731 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22051092 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14735736 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13096005 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10932100 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05685570 |
| 13 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.00717350 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00527502 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00527502 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.96162051 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87609139 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.84998908 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81004006 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80423785 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78099649 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76847400 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72513209 |
| 24 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.72384229 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71074007 |
| 26 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.69940217 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68988586 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65673883 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65152920 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64825949 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64357493 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61175125 |
| 33 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60714348 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59877402 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.58820336 |
| 36 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58768658 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58449483 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57098869 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56558983 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56303962 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55140625 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50719575 |
| 43 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49354449 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49354449 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.48955429 |
| 46 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.48798254 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48707754 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46080823 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45219677 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44795381 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.42074782 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41962958 |
| 53 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40773677 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39982064 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38511915 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36506822 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.35890544 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35036151 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32658152 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32339148 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31725695 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27454880 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26862544 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26311129 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26155318 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25298709 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24898967 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24556794 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23799885 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21517565 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20635679 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19887442 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19090896 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18507911 |
| 75 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16871889 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16074877 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14370986 |
| 78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14021873 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13831571 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13594483 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13039767 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12853117 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12638187 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12165096 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11553589 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10948341 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10622632 |
| 88 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10218804 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09609052 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09537089 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09383367 |
| 92 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09319881 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08921664 |
| 94 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08130969 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07560595 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06249966 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05948067 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05139534 |
| 99 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.04560355 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04273077 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02955047 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02907960 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02429200 |
| 104 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02399697 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01954458 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01954458 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01942852 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01440826 |
| 109 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01162201 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01116199 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00894714 |
| 112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.00881750 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00274112 |
| 114 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00138782 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00108199 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99450874 |
| 117 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99445920 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99304139 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98835608 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98723436 |
| 121 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98630979 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98474815 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98448798 |
| 124 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97919045 |
| 125 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97609673 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97516611 |
| 127 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97285587 |
| 128 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97187288 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97090959 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96896722 |
| 131 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96887772 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96715804 |
| 133 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96428084 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95185714 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94181245 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91603132 |
| 137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91330074 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90819437 |
| 139 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89998716 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89837627 |
| 141 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89485258 |
| 142 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89443799 |
| 143 | TBL1_22424771_ChIP-Seq_293T_Human | 0.88422382 |
| 144 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87549533 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87387576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.07237683 |
| 2 | MP0003880_abnormal_central_pattern | 4.07770594 |
| 3 | MP0003690_abnormal_glial_cell | 3.31038441 |
| 4 | MP0004270_analgesia | 3.24960696 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.24795759 |
| 6 | MP0004742_abnormal_vestibular_system | 2.85233263 |
| 7 | MP0001958_emphysema | 2.78048647 |
| 8 | MP0004885_abnormal_endolymph | 2.73356138 |
| 9 | MP0001486_abnormal_startle_reflex | 2.63559481 |
| 10 | MP0002064_seizures | 2.57960585 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.52458336 |
| 12 | MP0002272_abnormal_nervous_system | 2.48611161 |
| 13 | MP0003634_abnormal_glial_cell | 2.42692276 |
| 14 | MP0003329_amyloid_beta_deposits | 2.40773452 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.37830375 |
| 16 | MP0000778_abnormal_nervous_system | 2.37822126 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.35939408 |
| 18 | MP0005409_darkened_coat_color | 2.34849770 |
| 19 | MP0009046_muscle_twitch | 2.33682708 |
| 20 | MP0001905_abnormal_dopamine_level | 2.30043758 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.23162843 |
| 22 | MP0005171_absent_coat_pigmentation | 2.18456832 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.11457697 |
| 24 | MP0009745_abnormal_behavioral_response | 2.06547971 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.03264002 |
| 26 | MP0003632_abnormal_nervous_system | 2.02002961 |
| 27 | MP0004142_abnormal_muscle_tone | 2.01869523 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.97273058 |
| 29 | MP0001529_abnormal_vocalization | 1.93346331 |
| 30 | MP0002229_neurodegeneration | 1.92277695 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.84764586 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.84545758 |
| 33 | MP0000371_diluted_coat_color | 1.81882006 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.81411413 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.78148407 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.77025409 |
| 37 | MP0003136_yellow_coat_color | 1.76090609 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.74917803 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.69524925 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.68458086 |
| 41 | MP0005408_hypopigmentation | 1.64947947 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.64797038 |
| 43 | MP0000462_abnormal_digestive_system | 1.63515008 |
| 44 | MP0003091_abnormal_cell_migration | 1.63492935 |
| 45 | MP0000955_abnormal_spinal_cord | 1.62997709 |
| 46 | MP0008569_lethality_at_weaning | 1.62508808 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.61947081 |
| 48 | MP0003828_pulmonary_edema | 1.61025006 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.56666242 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.56173171 |
| 51 | MP0000604_amyloidosis | 1.56093398 |
| 52 | MP0010678_abnormal_skin_adnexa | 1.55808161 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.50644308 |
| 54 | MP0003724_increased_susceptibility_to | 1.48796559 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.48676362 |
| 56 | MP0004134_abnormal_chest_morphology | 1.46534858 |
| 57 | MP0003631_nervous_system_phenotype | 1.42442893 |
| 58 | MP0002009_preneoplasia | 1.39554741 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.39102158 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.36344049 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.35878633 |
| 62 | MP0000383_abnormal_hair_follicle | 1.34810900 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.33141834 |
| 64 | MP0004924_abnormal_behavior | 1.33141834 |
| 65 | MP0008260_abnormal_autophagy | 1.32238699 |
| 66 | MP0001970_abnormal_pain_threshold | 1.31784452 |
| 67 | MP0004883_abnormal_blood_vessel | 1.27109281 |
| 68 | MP0001299_abnormal_eye_distance/ | 1.25843403 |
| 69 | MP0001963_abnormal_hearing_physiology | 1.21941541 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.21578431 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.21403887 |
| 72 | MP0003633_abnormal_nervous_system | 1.20265775 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.13298114 |
| 74 | MP0004381_abnormal_hair_follicle | 1.13289851 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.12352358 |
| 76 | MP0003122_maternal_imprinting | 1.12271174 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.11922845 |
| 78 | MP0000747_muscle_weakness | 1.11111497 |
| 79 | MP0003879_abnormal_hair_cell | 1.10658352 |
| 80 | MP0002419_abnormal_innate_immunity | 1.10303542 |
| 81 | MP0002152_abnormal_brain_morphology | 1.08659976 |
| 82 | MP0002752_abnormal_somatic_nervous | 1.03433767 |
| 83 | MP0002184_abnormal_innervation | 1.03115268 |
| 84 | MP0001177_atelectasis | 1.02970624 |
| 85 | MP0000569_abnormal_digit_pigmentation | 1.01369891 |
| 86 | MP0005410_abnormal_fertilization | 1.00083983 |
| 87 | MP0003075_altered_response_to | 0.99588128 |
| 88 | MP0004811_abnormal_neuron_physiology | 0.99121393 |
| 89 | MP0008057_abnormal_DNA_replication | 0.98544886 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.97726274 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.97118431 |
| 92 | MP0003121_genomic_imprinting | 0.95660780 |
| 93 | MP0003123_paternal_imprinting | 0.95473008 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.94701456 |
| 95 | MP0002090_abnormal_vision | 0.94586875 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.93355826 |
| 97 | MP0003303_peritoneal_inflammation | 0.93247943 |
| 98 | MP0001968_abnormal_touch/_nociception | 0.93203748 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.90963190 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.89358380 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.89185825 |
| 102 | MP0001984_abnormal_olfaction | 0.89002887 |
| 103 | MP0003938_abnormal_ear_development | 0.88321157 |
| 104 | MP0000427_abnormal_hair_cycle | 0.87119194 |
| 105 | MP0001851_eye_inflammation | 0.87086084 |
| 106 | MP0003787_abnormal_imprinting | 0.86872394 |
| 107 | MP0005310_abnormal_salivary_gland | 0.86703618 |
| 108 | MP0002075_abnormal_coat/hair_pigmentati | 0.86107742 |
| 109 | MP0001324_abnormal_eye_pigmentation | 0.85745220 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.81870986 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.81250113 |
| 112 | MP0003045_fibrosis | 0.80864170 |
| 113 | MP0001661_extended_life_span | 0.79754389 |
| 114 | MP0005195_abnormal_posterior_eye | 0.78209002 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.77091784 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.76854035 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.75143351 |
| 118 | MP0001186_pigmentation_phenotype | 0.74616624 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.74142006 |
| 120 | MP0001502_abnormal_circadian_rhythm | 0.73898006 |
| 121 | MP0006054_spinal_hemorrhage | 0.72795398 |
| 122 | MP0002133_abnormal_respiratory_system | 0.71518105 |
| 123 | MP0005388_respiratory_system_phenotype | 0.71518105 |
| 124 | MP0003890_abnormal_embryonic-extraembry | 0.71499107 |
| 125 | MP0001727_abnormal_embryo_implantation | 0.70519683 |
| 126 | MP0004133_heterotaxia | 0.68763331 |
| 127 | MP0009115_abnormal_fat_cell | 0.68553758 |
| 128 | MP0004043_abnormal_pH_regulation | 0.68512772 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.68397018 |
| 130 | MP0005451_abnormal_body_composition | 0.68326101 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.68158292 |
| 132 | MP0001790_abnormal_immune_system | 0.67456474 |
| 133 | MP0005387_immune_system_phenotype | 0.67456474 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.65675632 |
| 135 | MP0000026_abnormal_inner_ear | 0.65348381 |
| 136 | MP0005174_abnormal_tail_pigmentation | 0.64951183 |
| 137 | MP0001835_abnormal_antigen_presentation | 0.64447936 |
| 138 | MP0003861_abnormal_nervous_system | 0.64371982 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.64069157 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.63003032 |
| 141 | MP0000372_irregular_coat_pigmentation | 0.62677013 |
| 142 | MP0006082_CNS_inflammation | 0.62580986 |
| 143 | MP0003937_abnormal_limbs/digits/tail_de | 0.62505602 |
| 144 | MP0005164_abnormal_response_to | 0.61894088 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.60478129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.44763096 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.44763096 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.35614075 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 5.19663206 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.83602526 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 4.82773580 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 4.61362664 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.38621654 |
| 9 | Parakeratosis (HP:0001036) | 4.19100552 |
| 10 | Spastic gait (HP:0002064) | 3.97556426 |
| 11 | Onion bulb formation (HP:0003383) | 3.60821048 |
| 12 | Akinesia (HP:0002304) | 3.55598119 |
| 13 | Dysmetria (HP:0001310) | 3.52092076 |
| 14 | Intention tremor (HP:0002080) | 3.48978360 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.46857490 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.30693927 |
| 17 | Abnormal auditory evoked potentials (HP:0006958) | 3.28837244 |
| 18 | Alacrima (HP:0000522) | 3.18945714 |
| 19 | Scanning speech (HP:0002168) | 3.12937947 |
| 20 | Slow saccadic eye movements (HP:0000514) | 3.09136382 |
| 21 | Termporal pattern (HP:0011008) | 3.04858726 |
| 22 | Insidious onset (HP:0003587) | 3.04858726 |
| 23 | Cerebral hypomyelination (HP:0006808) | 3.02297056 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.95546222 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92704405 |
| 26 | Anteriorly placed anus (HP:0001545) | 2.91278315 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.87798827 |
| 28 | Ankle clonus (HP:0011448) | 2.87749257 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.87170990 |
| 30 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.86026990 |
| 31 | Decreased lacrimation (HP:0000633) | 2.81621207 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.71796587 |
| 33 | Clumsiness (HP:0002312) | 2.71177181 |
| 34 | Bowel incontinence (HP:0002607) | 2.61340949 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 2.60789567 |
| 36 | Febrile seizures (HP:0002373) | 2.59778371 |
| 37 | Ocular albinism (HP:0001107) | 2.54267852 |
| 38 | Widely spaced teeth (HP:0000687) | 2.52245211 |
| 39 | Abnormal large intestine physiology (HP:0012700) | 2.52095032 |
| 40 | Myokymia (HP:0002411) | 2.50791162 |
| 41 | Premature skin wrinkling (HP:0100678) | 2.50133810 |
| 42 | Disinhibition (HP:0000734) | 2.49449009 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.48223146 |
| 44 | Blue irides (HP:0000635) | 2.46029901 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.45278626 |
| 46 | Atonic seizures (HP:0010819) | 2.44790458 |
| 47 | Thickened helices (HP:0000391) | 2.43728694 |
| 48 | Broad-based gait (HP:0002136) | 2.41381440 |
| 49 | Hypoplastic pelvis (HP:0008839) | 2.40936238 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.40325621 |
| 51 | Inappropriate behavior (HP:0000719) | 2.39730639 |
| 52 | Lower limb muscle weakness (HP:0007340) | 2.39586197 |
| 53 | Retinal dysplasia (HP:0007973) | 2.37920353 |
| 54 | Apathy (HP:0000741) | 2.36254289 |
| 55 | Iris hypopigmentation (HP:0007730) | 2.32911676 |
| 56 | Focal seizures (HP:0007359) | 2.31962194 |
| 57 | Small epiphyses (HP:0010585) | 2.28245191 |
| 58 | Hematochezia (HP:0002573) | 2.27564454 |
| 59 | Generalized hypopigmentation of hair (HP:0011358) | 2.27408842 |
| 60 | Morphological abnormality of the inner ear (HP:0011390) | 2.27000837 |
| 61 | Action tremor (HP:0002345) | 2.21438554 |
| 62 | Gingivitis (HP:0000230) | 2.19808214 |
| 63 | Mutism (HP:0002300) | 2.19282899 |
| 64 | Arterial tortuosity (HP:0005116) | 2.16336812 |
| 65 | Subacute progressive viral hepatitis (HP:0006572) | 2.15283664 |
| 66 | Periodontitis (HP:0000704) | 2.14627015 |
| 67 | Overgrowth (HP:0001548) | 2.13587108 |
| 68 | Diminished motivation (HP:0000745) | 2.12444559 |
| 69 | Focal motor seizures (HP:0011153) | 2.10845828 |
| 70 | Cupped ear (HP:0000378) | 2.06665248 |
| 71 | Spondylolisthesis (HP:0003302) | 2.06518373 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.06279631 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05895912 |
| 74 | Partial agenesis of the corpus callosum (HP:0001338) | 2.04848849 |
| 75 | Hypokalemic alkalosis (HP:0001949) | 2.04206064 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.03966923 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03850094 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.03850094 |
| 79 | Amyloidosis (HP:0011034) | 2.03732288 |
| 80 | Increased circulating renin level (HP:0000848) | 2.03378142 |
| 81 | Absent speech (HP:0001344) | 2.02760992 |
| 82 | Relative macrocephaly (HP:0004482) | 2.02722942 |
| 83 | Urinary incontinence (HP:0000020) | 2.01560837 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01434194 |
| 85 | Urinary urgency (HP:0000012) | 2.00874607 |
| 86 | Cerebral aneurysm (HP:0004944) | 1.99966283 |
| 87 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.99202933 |
| 88 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97180275 |
| 89 | Decreased motor nerve conduction velocity (HP:0003431) | 1.96964970 |
| 90 | Drooling (HP:0002307) | 1.95937155 |
| 91 | Excessive salivation (HP:0003781) | 1.95937155 |
| 92 | CNS hypomyelination (HP:0003429) | 1.95147854 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 1.94570270 |
| 94 | Metabolic alkalosis (HP:0200114) | 1.94483753 |
| 95 | Autoamputation (HP:0001218) | 1.92685936 |
| 96 | Stridor (HP:0010307) | 1.92343575 |
| 97 | Papilledema (HP:0001085) | 1.92119998 |
| 98 | Agitation (HP:0000713) | 1.91911097 |
| 99 | Absent frontal sinuses (HP:0002688) | 1.91753986 |
| 100 | Vascular tortuosity (HP:0004948) | 1.91626683 |
| 101 | Loss of speech (HP:0002371) | 1.90698912 |
| 102 | Spastic paraparesis (HP:0002313) | 1.89860050 |
| 103 | Macroorchidism (HP:0000053) | 1.89658784 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89299810 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89299810 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89299810 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 1.89097539 |
| 108 | Hip dysplasia (HP:0001385) | 1.88497786 |
| 109 | Spastic tetraparesis (HP:0001285) | 1.88241382 |
| 110 | Agammaglobulinemia (HP:0004432) | 1.87612469 |
| 111 | Clonus (HP:0002169) | 1.86294238 |
| 112 | Dialeptic seizures (HP:0011146) | 1.85736737 |
| 113 | Epileptic encephalopathy (HP:0200134) | 1.85463633 |
| 114 | Paraparesis (HP:0002385) | 1.83900866 |
| 115 | Overriding aorta (HP:0002623) | 1.83348282 |
| 116 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.83241143 |
| 117 | Aqueductal stenosis (HP:0002410) | 1.81724816 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81680973 |
| 119 | Absent septum pellucidum (HP:0001331) | 1.81467888 |
| 120 | Increased CSF protein (HP:0002922) | 1.81371073 |
| 121 | Generalized hypopigmentation (HP:0007513) | 1.80765312 |
| 122 | Dysdiadochokinesis (HP:0002075) | 1.79133368 |
| 123 | Hypoplasia of the iris (HP:0007676) | 1.78660587 |
| 124 | Myocardial infarction (HP:0001658) | 1.78655144 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 1.78607173 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.78607173 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.78607173 |
| 128 | Postural instability (HP:0002172) | 1.77211403 |
| 129 | Truncal ataxia (HP:0002078) | 1.76845265 |
| 130 | Peripheral demyelination (HP:0011096) | 1.76590271 |
| 131 | Abnormality of the parathyroid morphology (HP:0011766) | 1.76067226 |
| 132 | Esophageal atresia (HP:0002032) | 1.75818887 |
| 133 | Split foot (HP:0001839) | 1.75577224 |
| 134 | Progressive cerebellar ataxia (HP:0002073) | 1.75288169 |
| 135 | Bladder neoplasm (HP:0009725) | 1.75235189 |
| 136 | Bladder carcinoma (HP:0002862) | 1.75235189 |
| 137 | Abnormality of the periventricular white matter (HP:0002518) | 1.73876580 |
| 138 | Abnormality of binocular vision (HP:0011514) | 1.73169341 |
| 139 | Diplopia (HP:0000651) | 1.73169341 |
| 140 | Diminished movement (HP:0002374) | 1.72604716 |
| 141 | Global brain atrophy (HP:0002283) | 1.71586494 |
| 142 | Tubulointerstitial fibrosis (HP:0005576) | 1.71217389 |
| 143 | Asymmetry of the thorax (HP:0001555) | 1.70780857 |
| 144 | Large earlobe (HP:0009748) | 1.70555219 |
| 145 | Infantile muscular hypotonia (HP:0008947) | 1.70231007 |
| 146 | Pheochromocytoma (HP:0002666) | 1.69939199 |
| 147 | Hyperventilation (HP:0002883) | 1.69379685 |
| 148 | Spastic paraplegia (HP:0001258) | 1.68405645 |
| 149 | Neoplasm of the heart (HP:0100544) | 1.68096468 |
| 150 | Distal sensory impairment (HP:0002936) | 1.68073868 |
| 151 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.67661979 |
| 152 | Frequent falls (HP:0002359) | 1.66471712 |
| 153 | Hemiplegia (HP:0002301) | 1.63826377 |
| 154 | Spontaneous hematomas (HP:0007420) | 1.63654676 |
| 155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.61812245 |
| 156 | Neoplasm of the adrenal cortex (HP:0100641) | 1.61806659 |
| 157 | Recurrent skin infections (HP:0001581) | 1.61199284 |
| 158 | Germ cell neoplasia (HP:0100728) | 1.60501536 |
| 159 | Osteolytic defects of the hand bones (HP:0009699) | 1.60423293 |
| 160 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.60423293 |
| 161 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.60368346 |
| 162 | Striae distensae (HP:0001065) | 1.59319477 |
| 163 | Dysmetric saccades (HP:0000641) | 1.58964236 |
| 164 | Thyroid carcinoma (HP:0002890) | 1.57857188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.87650014 |
| 2 | OXSR1 | 3.99732053 |
| 3 | EPHB1 | 3.33181327 |
| 4 | TNIK | 2.91261835 |
| 5 | FRK | 2.79836031 |
| 6 | PKN1 | 2.68725918 |
| 7 | CDK19 | 2.55982812 |
| 8 | PNCK | 2.46312244 |
| 9 | MAPKAPK5 | 2.22727327 |
| 10 | FGFR2 | 2.07978495 |
| 11 | WNK1 | 2.03297645 |
| 12 | SGK2 | 1.98256754 |
| 13 | MARK1 | 1.90771090 |
| 14 | UHMK1 | 1.87257936 |
| 15 | PRPF4B | 1.81016476 |
| 16 | SGK3 | 1.80469036 |
| 17 | FGFR3 | 1.76883356 |
| 18 | FES | 1.73132630 |
| 19 | ICK | 1.69319709 |
| 20 | NTRK1 | 1.68849883 |
| 21 | KSR1 | 1.67656945 |
| 22 | PAK6 | 1.65787451 |
| 23 | NEK6 | 1.63299665 |
| 24 | CLK1 | 1.60709272 |
| 25 | BCR | 1.58940290 |
| 26 | CSNK1G3 | 1.55687429 |
| 27 | CSNK1A1L | 1.50177147 |
| 28 | LIMK1 | 1.46674364 |
| 29 | FGR | 1.45243614 |
| 30 | WNK4 | 1.40567028 |
| 31 | DAPK2 | 1.40077731 |
| 32 | MET | 1.36347743 |
| 33 | TYK2 | 1.35412903 |
| 34 | TYRO3 | 1.34063035 |
| 35 | ACVR1B | 1.32916534 |
| 36 | CAMK1D | 1.31488718 |
| 37 | CAMK2B | 1.31203311 |
| 38 | CSNK1G2 | 1.30666695 |
| 39 | MARK2 | 1.29705434 |
| 40 | TGFBR2 | 1.29538643 |
| 41 | ROCK2 | 1.28935866 |
| 42 | BLK | 1.28783991 |
| 43 | KSR2 | 1.26237412 |
| 44 | CSNK1G1 | 1.21797730 |
| 45 | CAMK1G | 1.18649575 |
| 46 | LATS1 | 1.17386140 |
| 47 | STK38L | 1.17305612 |
| 48 | JAK1 | 1.15071018 |
| 49 | AKT3 | 1.14678568 |
| 50 | LATS2 | 1.13798427 |
| 51 | STK38 | 1.12196053 |
| 52 | MAPK15 | 1.09580023 |
| 53 | SIK3 | 1.09530046 |
| 54 | MAP3K13 | 1.07922258 |
| 55 | PAK3 | 1.07515398 |
| 56 | EPHA4 | 1.06866903 |
| 57 | MAP3K9 | 1.05654209 |
| 58 | NEK9 | 1.04891789 |
| 59 | PRKD3 | 1.04318372 |
| 60 | NTRK3 | 1.03827110 |
| 61 | CSF1R | 0.99096625 |
| 62 | CASK | 0.98333676 |
| 63 | FER | 0.97994330 |
| 64 | RET | 0.97883814 |
| 65 | CDK5 | 0.96784161 |
| 66 | SGK494 | 0.95278673 |
| 67 | SGK223 | 0.95278673 |
| 68 | MAP3K6 | 0.94982888 |
| 69 | MAPK13 | 0.91919090 |
| 70 | CAMK2D | 0.91165284 |
| 71 | PDGFRA | 0.87623907 |
| 72 | NLK | 0.87127074 |
| 73 | FYN | 0.83720064 |
| 74 | CAMKK1 | 0.83210483 |
| 75 | HIPK2 | 0.81271897 |
| 76 | PRKCQ | 0.81028225 |
| 77 | JAK2 | 0.80783325 |
| 78 | NTRK2 | 0.80430579 |
| 79 | ERBB3 | 0.78920793 |
| 80 | CDK14 | 0.78831915 |
| 81 | MAP3K14 | 0.78048221 |
| 82 | CDK15 | 0.76583365 |
| 83 | CDK6 | 0.74861310 |
| 84 | MAP2K4 | 0.74782872 |
| 85 | PBK | 0.74224754 |
| 86 | DYRK2 | 0.73916816 |
| 87 | MAP3K1 | 0.73612420 |
| 88 | STK11 | 0.72437163 |
| 89 | RPS6KA2 | 0.72158847 |
| 90 | ERBB2 | 0.71726104 |
| 91 | ZAP70 | 0.71714398 |
| 92 | IRAK2 | 0.71053975 |
| 93 | PRKD1 | 0.70650705 |
| 94 | PDGFRB | 0.69519660 |
| 95 | CSK | 0.68982439 |
| 96 | CDK18 | 0.68975995 |
| 97 | TESK2 | 0.68364622 |
| 98 | SIK2 | 0.67876815 |
| 99 | CDK11A | 0.66052572 |
| 100 | STK24 | 0.65054611 |
| 101 | RIPK4 | 0.62367171 |
| 102 | CDK12 | 0.61759584 |
| 103 | CAMK2A | 0.61473493 |
| 104 | EPHA3 | 0.60631149 |
| 105 | CSNK1D | 0.60316885 |
| 106 | PINK1 | 0.60041545 |
| 107 | RIPK1 | 0.59191331 |
| 108 | PLK2 | 0.58975603 |
| 109 | PDPK1 | 0.58099196 |
| 110 | DYRK1A | 0.55851257 |
| 111 | MINK1 | 0.54794692 |
| 112 | TRPM7 | 0.52632940 |
| 113 | CDC42BPA | 0.52294678 |
| 114 | PRKCH | 0.52291528 |
| 115 | CAMK2G | 0.52110205 |
| 116 | PRKCE | 0.51154210 |
| 117 | PRKCZ | 0.51084710 |
| 118 | MAPK12 | 0.49990681 |
| 119 | PRKG1 | 0.49154318 |
| 120 | ALK | 0.49120550 |
| 121 | MAP3K2 | 0.48614324 |
| 122 | PKN2 | 0.48609859 |
| 123 | MKNK1 | 0.47771651 |
| 124 | FGFR1 | 0.47752543 |
| 125 | IRAK4 | 0.47377059 |
| 126 | CAMK4 | 0.46893904 |
| 127 | LCK | 0.45837736 |
| 128 | INSR | 0.45286759 |
| 129 | MAPK7 | 0.44945806 |
| 130 | MST4 | 0.44498954 |
| 131 | HCK | 0.43462971 |
| 132 | BRD4 | 0.43336217 |
| 133 | PDK1 | 0.42764945 |
| 134 | ADRBK2 | 0.42025808 |
| 135 | MAPK10 | 0.41401462 |
| 136 | MAP3K4 | 0.41231778 |
| 137 | MAP4K1 | 0.38996591 |
| 138 | IRAK1 | 0.37723428 |
| 139 | SGK1 | 0.37677009 |
| 140 | ITK | 0.37336252 |
| 141 | BMPR2 | 0.37016900 |
| 142 | GSK3A | 0.36324037 |
| 143 | PAK2 | 0.35508811 |
| 144 | DMPK | 0.35435652 |
| 145 | MELK | 0.34535626 |
| 146 | CAMKK2 | 0.33340848 |
| 147 | RPS6KA5 | 0.33314552 |
| 148 | YES1 | 0.32104319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.09913633 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.29041813 |
| 3 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.55159441 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.52407827 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.19477047 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.18395472 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.11645468 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90856581 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.81487592 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.62848759 |
| 11 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.62166429 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61731370 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.60133492 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.59271286 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.57355111 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56436358 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51271601 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49371237 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44721023 |
| 20 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.44583105 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34307018 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.28240996 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.26710076 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24801462 |
| 25 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.24647706 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24486878 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23134781 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21643284 |
| 29 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.20927302 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.20805350 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20312430 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19771462 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.19115657 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18894637 |
| 35 | Endocytosis_Homo sapiens_hsa04144 | 1.17940695 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.17931172 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17578109 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17131015 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16841875 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15237439 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14830754 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13656331 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13526421 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.13396384 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11629557 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10087842 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09404798 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.07985852 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05795606 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04519256 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03163965 |
| 52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02574147 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00215307 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99144269 |
| 55 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.93777493 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93538752 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.92187713 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91638745 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91165963 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89716912 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88110589 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87416634 |
| 63 | Protein export_Homo sapiens_hsa03060 | 0.87110831 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86815191 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86697171 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84345718 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83390273 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82902061 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.82031728 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81158968 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.80880037 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80867240 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.80381581 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80316028 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79726812 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79380025 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78641548 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78438477 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78343292 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77562987 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.76584144 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76485372 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76458542 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76403745 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75920870 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.75030900 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73807154 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73650596 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73018374 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72634028 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70973916 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.70059721 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70050012 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69144590 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.69084549 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.68570570 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68316886 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67910402 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67009843 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66570660 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66393270 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64840863 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63915294 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63460473 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63086812 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62913166 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62351260 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.62013840 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61972396 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61473706 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59167786 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59084665 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58967558 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57335433 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57003571 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55837462 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.54374511 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54229688 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.53766767 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49718687 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | 0.48736182 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.46632843 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45497079 |
| 124 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45384090 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45094358 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42773821 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41984171 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.41432350 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39865933 |
| 130 | Melanogenesis_Homo sapiens_hsa04916 | 0.39559893 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38508605 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38338951 |

